yair lotan, md, regarding the role of molecular markers in high-risk bladder cancer patients
Published 6 years ago • 103 plays • Length 1:34
Download video MP4
Download video MP3
Similar videos
-
1:40
yair lotan, md, on molecular characterization & subtyping data in bladder cancer
-
1:54
yair lotan, md, considers the role of checkpoint inhibitors in bladder cancer
-
3:32
yair lotan, md, on the challenges using biomarkers for treatment selection in bladder cancer
-
1:54
yair lotan, md, considers the latest in screening for high-risk asymptomatic bladder cancer
-
1:49
yair lotan, md, shares outcomes of keynote 057 in high-risk non-muscle-invasive bladder cancer
-
8:26
the role of molecular markers in bladder cancer
-
49:48
adjuvant therapy for high risk bladder cancer w/ dr. yair lotan & dr. suzanne cole | ep. 103
-
1:21
yair lotan, md, explains how new guidelines have changed the treatment of bladder cancer
-
1:10
yair lotan, md, on how multi-modality treatment is being applied to locally advanced bladder cancer
-
0:46
molecular markers guiding treatment approaches in bladder cancer
-
2:43
genomic insights and biomarkers for treatment selection in bladder cancer
-
1:34
yair lotan, md, considers the implications of the pout study presented at asco gu 2018
-
43:48
urinary molecular marker tests in bladder cancer: an overview of cxbladder
-
8:32
the role of molecular markers in bladder cancer from asco gu 2017
-
1:26
analyzing the role of molecular profiling in patients with bladder cancer
-
53:23
bladder cancer tests, diagnosis and recurrence
-
1:45
peter c. black, md, facs, frcsc, on the usefulness of molecular markers in bladder cancer treatment
-
14:56
natural history and surveillance of bladder cancer
-
1:21
jeanny b. aragon-ching, md, facp, on molecular markers in high-risk muscle-invasive bladder cancer
Clip.africa.com - Privacy-policy